inVentiv Health Clinics Logo
|
  • Contact Us
  • |
  • RFP
  • | 
  • Media Center
  • |
  • Study Participants
  • |
  • Investigators
  • |
  • Français
    • Overview
    • History
    • Leadership Team
    • Corporate Responsibility
    • Overview
    • Phase I-IIa
      • First-in-Man
        • Diverse Experience
        • Modern Facilities
        • Project Management
        • Rapid Recruitment
      • Proof-of-Concept
      • Bioavailability / Bioequivalence / Biosimilars
      • Drug Drug Interaction
      • QT/TQT Capabilities
      • Special Populations
    • Bioanalytical
      • Non-GLP Analysis
      • Method Development & Validation
      • Biomarkers
      • Large Molecule Analysis
      • Clinical Lab
      • Assay List
      • Instrumentation
    • Phase IIb-III
      • Biostatistics and Statistical Programming
      • Clinical Monitoring
      • Data Management
      • Feasibility Studies
      • Global Safety and Pharmacovigilance
      • Interactive Response Technologies
      • Investigator Recruitment and Site Management
      • Medical and Scientific Affairs
      • Medical Writing
      • Project Management
      • Patient Recruitment Services
        • Program Branding and Communications
        • Advertising and Promotion
        • Referral Network Management
      • Rater Training
    • Late Stage
      • Observational Research and Patient Registries
      • Interventional IIIB/IV Studies
      • Health Economics and Outcomes Research
      • Risk Management and Epidemiology
    • Quality Assurance
    • Consulting
      • 505(b)(2)
      • Biostatistics
      • Business Plan Services
      • Chemistry, Manufacturing, and Controls (CMC)
      • Clinical and Product Development
      • Global Safety and Pharmacovigilance
      • Pharmacokinetics and Pharmacodynamics (PK/PD)
      • Regulatory Services
    • Functional Services
    • Clinical Staffing
    • Permanent Recruitment
    • Therapeutic Overview
    • Clinical Development Expertise
      • Biosimilars
      • Generics
      • Pediatrics
      • Small Molecule Therapeutics
    • Therapeutic Indications
      • Cardiovascular
      • Infectious Diseases/Vaccines
      • Neuroscience
      • Oncology
      • Pain
    • Locations
    • Asia Pacific
      • Mandarin
    • Europe
    • Latin America
    • North America
    • Overview
    • Articles
    • Brochures
    • Case Studies
    • Fact Sheets
    • inVentiv Health Clinical Publications
    • Posters
    • Presentations
    • Videos/Podcasts/Webinars
    • White Papers
    • Overview
    • FAQ
    • Job Opportunities
    • Training Programs
Print
this page 		Email to
a Friend
Overview
Articles
Brochures
Case Studies
Fact Sheets
inVentiv Health Clinical Publications
Posters
Presentations
Videos/Podcasts/Webinars
White Papers

White Papers

Considerations When Selecting A CRO For Phase I Clinical Studies (197 KB)
Eight Steps to More Productive Observational Studies (139.86 KB)
Top Nine Opportunities for Improving Observation Research (216.9 KB)
Unblinded Monitoring in HCV Trials (85.18 KB)

  • 504 Carnegie Center, Princeton, NJ 08540 USA
  • |
  • Phone: +1-609-951-6800
  • |
  • Email: pni@inventivhealth.com
  • |
  • Site Map
  • |
  • Privacy Policy
  • |
  • Terms & Conditions
  •